Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Non Operating Income (2021 - 2025)

Historic Non Operating Income for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to $982000.0.

  • Pulse Biosciences' Non Operating Income rose 71.79% to $982000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 7587.65%. This contributed to the annual value of $2.7 million for FY2024, which is 9589.44% up from last year.
  • Latest data reveals that Pulse Biosciences reported Non Operating Income of $982000.0 as of Q3 2025, which was up 71.79% from $1.1 million recorded in Q2 2025.
  • Pulse Biosciences' Non Operating Income's 5-year high stood at $1.2 million during Q1 2025, with a 5-year trough of -$452000.0 in Q4 2022.
  • For the 5-year period, Pulse Biosciences' Non Operating Income averaged around $431937.5, with its median value being $410500.0 (2024).
  • In the last 5 years, Pulse Biosciences' Non Operating Income crashed by 743333.33% in 2022 and then skyrocketed by 500000.0% in 2023.
  • Over the past 5 years, Pulse Biosciences' Non Operating Income (Quarter) stood at -$6000.0 in 2021, then tumbled by 7433.33% to -$452000.0 in 2022, then soared by 232.74% to $600000.0 in 2023, then soared by 46.0% to $876000.0 in 2024, then rose by 12.1% to $982000.0 in 2025.
  • Its Non Operating Income stands at $982000.0 for Q3 2025, versus $1.1 million for Q2 2025 and $1.2 million for Q1 2025.